This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Cancer of liver and bile duct
  • /
  • BSG guidelines for the diagnosis and management of...
Guideline

BSG guidelines for the diagnosis and management of cholangiocarcinoma

Read time: 1 mins
Last updated:29th Sep 2023
Status: Live
British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of cholangiocarcinoma


These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.


Read full Guideline